Delayed cerebral ischemia occurs in about 30% of patients during the first 2 weeks after subarachnoid hemorrhage, and can result in substantial disability and death. Research studies investigating the incidence of delayed cerebral ischemia and strategies for prevention and treatment are hampered by inconsistent use of terminology and definitions for this complication, and by reliance on indirect surrogate markers of ischemia. A literature review was conducted to search for studies that addressed the issue of inconsistent definitions of delayed cerebral ischemia through December 2010. A total of four studies were identified. Original research studies and consensus panel recommendations for definitions support limiting the use of combined measures that include both clinical and radiographic assessments, as well as indirect measures, and the current usage of the term vasospasm. Cerebral infarction was supported as the most appropriate definition for delayed cerebral ischemia in the context of clinical trials. © Springer Science+Business Media, LLC 2011.

Vergouwen, M., Citerio, G. (2011). Vasospasm versus delayed cerebral ischemia as an outcome event in clinical trials and observational studies. NEUROCRITICAL CARE, 15(2), 308-311 [10.1007/s12028-011-9586-8].

Vasospasm versus delayed cerebral ischemia as an outcome event in clinical trials and observational studies

CITERIO, GIUSEPPE
2011

Abstract

Delayed cerebral ischemia occurs in about 30% of patients during the first 2 weeks after subarachnoid hemorrhage, and can result in substantial disability and death. Research studies investigating the incidence of delayed cerebral ischemia and strategies for prevention and treatment are hampered by inconsistent use of terminology and definitions for this complication, and by reliance on indirect surrogate markers of ischemia. A literature review was conducted to search for studies that addressed the issue of inconsistent definitions of delayed cerebral ischemia through December 2010. A total of four studies were identified. Original research studies and consensus panel recommendations for definitions support limiting the use of combined measures that include both clinical and radiographic assessments, as well as indirect measures, and the current usage of the term vasospasm. Cerebral infarction was supported as the most appropriate definition for delayed cerebral ischemia in the context of clinical trials. © Springer Science+Business Media, LLC 2011.
Articolo in rivista - Articolo scientifico
Angiography; Cerebral infarction; Clinical deterioration; Transcranial Doppler; Vasospasm; Cerebral Infarction; Clinical Trials as Topic; Critical Care; Humans; Subarachnoid Hemorrhage; Time Factors; Vasospasm, Intracranial; Outcome Assessment (Health Care); Neurology (clinical); Critical Care and Intensive Care Medicine
English
2011
15
2
308
311
open
Vergouwen, M., Citerio, G. (2011). Vasospasm versus delayed cerebral ischemia as an outcome event in clinical trials and observational studies. NEUROCRITICAL CARE, 15(2), 308-311 [10.1007/s12028-011-9586-8].
File in questo prodotto:
File Dimensione Formato  
Neurocri Care 2011 Vergouwen.pdf

accesso aperto

Dimensione 163.28 kB
Formato Adobe PDF
163.28 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/54853
Citazioni
  • Scopus 108
  • ???jsp.display-item.citation.isi??? 101
Social impact